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http://dx
AObjective: Robotic total endoscopic coronary artery bypass grafting (TECAB) has been under development for
10 years. With increasing experience and technological improvement, double-vessel TECAB has become fea-
sible. The aim of the present study was to compare the current outcomes of single- and double-vessel TECAB.
Methods: Between 2001 and 2011, 484 patients underwent TECAB by 4 surgeons at 2 institutions. The median
patient agewas 60 years (range, 31-90), and the median European System for Cardiac Operative Risk Evaluation
was 2 (range, 0-13). Single-vessel (n ¼ 334) and double-vessel (n ¼ 150) procedures were performed using the
da Vinci, da Vinci S, and da Vinci Si robotic systems.
Results: Compared with the single-vessel procedure, double-vessel TECAB required a longer operative time
(median, 375 minutes; range, 168-795; vs median, 240; range, 112-605; P<.001) and had an increased conver-
sion rate to a larger thoracic incision (31/150 [20.7%] vs 31/334 [9.3%]; P<.001). The median ventilation time
was 10 hours (range, 0-288) for double-vessel versus 8 hours (range, 0-278) for single-vessel procedures
(P ¼ .006). The hospital stay was comparable, with 6 days (range, 2-27) for double-vessel TECAB and 6
days (range, 2-33) for single-vessel TECAB (P ¼ .794). Perioperative mortality was 0.3% (1/334) with
single-vessel TECAB and 2.0% (3/150) with double-vessel TECAB (P ¼ .090). Freedom from major adverse
cardiac and cerebral events at 5 years was similar after double- and single-vessel TECAB (73.5% vs 83.1%,
P ¼ .150). The 5-year survival was 95.8% and 93.9% (P ¼ .708).
Conclusions: Double-vessel TECAB appears feasible and reproducible. The operative times were longer and
the conversion rates to a larger thoracic incision were greater than with single-vessel TECAB. Also, the post-
operative ventilation time was longer. Other perioperative morbidity and mortality and the recovery time and
long-term clinical outcomes, however, were comparable. (J Thorac Cardiovasc Surg 2012;144:1061-6)Double-vessel total endoscopic coronary artery bypass
grafting (TECAB) represents a second generation of
closed-chest coronary bypass grafting procedures. With ap-
plication of robotic technology, the procedures are per-
formed using ports, without the need for thoracotomy.
After an initial phase in which only single-vessel coronary
artery bypass grafting procedures were performed using ro-
botics, some groups reported successful first case reports of
double-vessel TECAB.1,2 A first small series was published
by our group in 2007.3 To date, little information is avail-
able on the intraoperative performance, perioperativeniversity of Maryland School of Medicine,a Baltimore, Md; and Innsbruck
cal University,b Innsbruck, Austria.
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The Journal of Thoracic and Carresults, and long-term outcomes of double-vessel TECAB.
We, therefore, analyzed a series of 150 double-vessel TE-
CABs and compared these with a series of single-vessel
TECABs performed during the same study period.
METHODS
From 2001 to 2011, 334 single-vessel and 150 double-vessel TECAB
procedures were performed using the da Vinci, da Vinci S, and da Vinci
Si robotic systems (Intuitive Surgical, Inc, Sunnyvale, Calif). The opera-
tions were performed at the Innsbruck Medical University and the Univer-
sity of Maryland Medical Center by 4 console surgeons (J.B., T.S., N.B.,
and E.L.). The demographic data for the whole study population are listed
in Table 1, and the procedures performed are listed in Table 2.
General Surgical Technique
All operations were performed with the patients under general anesthe-
sia with double-lumen tube intubation. The patients were placed in the su-
pine position with the left or right chest slightly elevated. Percutaneous
defibrillator patches were placed preoperatively.
Ports were placed under ipsilateral lung collapse. A camera port was in-
serted into the left fifth intercostal space, and instrument ports were in-
serted into the third and seventh intercostal spaces. Assistance ports were
created in the subcostal region for the EndoWrist (Intuitive Surgical, Inc)
endostabilizer and in the parasternal region for transthoracic assistance.
The internal thoracic artery (ITA) was harvested using a pedicled technique
during the early phase of our series and was skeletonized during the laterdiovascular Surgery c Volume 144, Number 5 1061
TABLE 2. Procedures performed
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
ITA ¼ internal thoracic artery
TECAB ¼ total endoscopic coronary artery bypass
grafting
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Dphases. For revascularization of the right coronary artery territory ports
were placed on the right side of the chest, mirroring the left-sided port
placements. During the very last phase of our experience, the right coronary
artery systemwas also approached from the patient’s left side. For exposure
of the lateral and back walls of the heart, the endoscopic stabilizer was
used. All anastomoses were created using a short, double-armed 7-0 poly-
propylene suture.
The arrested heart technique for TECAB has been previously described,
and videos of this procedure are available on OR-LIVE.com (available
from: http://www.orlive.com/umm/videos/tecab-totally-endoscopic-coro
nary-artery-bypass) and the Minimally Invasive Robotic Association
Web site (available from: http://www.miraweb.org/video.htm).4 The proce-
dures were performed using remote-access heart–lung machine perfusion
and ascending aorta balloon occlusion for cardioplegia. For creation of by-
pass grafts on the beating heart, a suction stabilizer was used, as described
previously.5 The target vessel was encircled with Silastic tapes, and shunts
were used during the later phase of our series. Also during the later phase,
patients were cannulated prophylactically, and the heart–lung machine was
used in cases of significant space constraints, for exposure of the back wall
of the heart, or in the case of hemodynamic instability. We described this
cannulation technique in 2009.6TABLE 1. Demographic data
Variable
Single-vessel
TECAB
Double-vessel
TECAB
P
value
Patients (n) 334 150
Age (y) 60 (31-90) 61 (38-83) .178
Men 233 (69.8%) 117 (78.0%)
Women 101 (31.2%) 33 (22.0%) .150
Height (cm) 172 (137-196) 173 (142-188) .766
Weight (kg) 80 (48-158) 80 (41-180) .393
BMI (kg/m2) 27 (18-47) 28 (14-46) .379
CVI 23 (7.0%) 21 (14.0%) .012
Peripheral vascular disease 22 (6.6%) 9 (6.0%) .492
Dialysis 8 (2.4%) 0 (0.0%) .05
Preoperative creatinine 0.98 (0.56-12.0) 0.94 (0.48-2.0) .082
Prophylactic IABP 14 (4.2%) 7 (4.7%) .802
Previous myocardial
infarction
91 (27.2%) 61 (40.7%) .002
LVEF (%) 60 (20-88) 60 (25-80) .125
STS risk score (%) 0.59 (0.18-0.99) 0.57 (0.18-0.62) .448
EuroSCORE .136
Median 2 2
Range 0-13 0-7
Mean  SD 2.17  2.24 2.35  1.94
Learning curve cases 113 (33.8%) 105 (70.0%) .001
Data presented as n (%) or median (range), unless noted otherwise. TECAB, Total en-
doscopic coronary artery bypass grafting; BMI, body mass index; CVI, chronic ve-
nous insufficiency; IABP, intra-aortic balloon pump; LVEF, left ventricular ejection
fraction; STS, Society of Thoracic Surgeons; EuroSCORE, European System for Car-
diac Operative Risk Evaluation.
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The first 20 cases of a new procedure variation for a single surgeon were
defined as the learning curve cases and were documented as such. Of the
334 single-vessel TECAB cases and 150 double-vessel TECAB cases,
112 (33.5%) and 105 (70.0%) were a part of a single surgeon’s learning
curve, respectively (P<.001). The operative time was defined as the inter-
val from skin incision to skin closure. Conversion was defined as the need
to open the chest through a larger incision such as sternotomy or thoracot-
omy because of technical difficulties or inadequate intraoperative
revascularization.
Statistical Analysis
The data were collected prospectively, entered into an institutional re-
view board-approved database, and analyzed using the IBM SPSS, version
19.0 (IBM Corp, Armonk, NY), statistical software package. Continuous
variables are presented as medians and ranges and categorical variables
as absolute values and percentages. Comparisons between single- and
double-vessel TECAB were done using the Mann Whitney-U test for con-
tinuous variables and the c2 test or Fisher exact test for categorical vari-
ables, as appropriate. Long-term survival and freedom from adverse
events were calculated using the Kaplan-Meier method. For comparison
between groups, we used the log-rank test.RESULTS
Of all the procedures, 303 of 334 single-vessel TECAB
and 119 of 150 double-vessel TECAB were completed totalVariable
Arrested
heart
Beating
heart
Single vessel
LITA to LAD 234 75
LITA to Dg 8
LITA to OM 6 1
RITA to LAD 3 2
RITA to RCA 3
LITA to LAD (from right side) 1
RITA to LAD (from right side) 1
Total 256 78
Double vessel
RITA LADþLITA Dg/OM/Cx 62 14
LITA to LAD/LAD jump 34 3
RITA to LAD, LITAY-graft to PDA 5
LITA to LAD, RITAY-graft to PDA 4 1
LITA to LAD, RITA to RCA (from right) 3
RITA to LAD, LITAY-graft to RCA (from right) 5
LITA to LAD, RITAY-graft to OM 2
LITA to LAD, SVG to RCA (from right) 3
LITA to LAD, SVG to Dg 1 2
LITA to LAD, SVG to OM 1 3
LITA to OM/ramus jump 1
RITA/RA composite to Dg/OM 1
LITA to LAD, RITA to Dg 3
LITA to LAD/Dg jump 2
Total 122 28
LITA, Left internal thoracic artery; LAD, left anterior descending artery; Dg, diagonal
branch; OM, obtuse marginal branch; RITA, right internal thoracic artery; RCA, right
coronary artery; Cx, circumflex artery; PDA, posterior descending artery; SVG, saphe-
nous vein graft.
gery c November 2012
TABLE 4. Postoperative results
Variable
Single-vessel
TECAB
Double-vessel
TECAB P value
Patients (n) 334 150
Revision for bleeding 21 (6.3%) 7 (4.7%) .317
Packed red blood cells 1 (0-28) 2 (0-27) .002
Intra-aortic balloon pump 4 (1.2%) 2 (1.3%) .602
Atrial fibrillation 50 (15.0%) 21 (13.8%) .336
Ventilation time (h) 8 (0-278) 10 (0-288) .006
Pneumonia 10 (3.0%) 10 (6.7%) .055
Venoarterial ECMO 0 (0.0%) 1 (0.7%) .310
CVVH 3 (0.9%) 4 (2.7%) .138
Transitory ischemic attack 0 (0.0%) 2 (1.3%) .096
Stroke 6 (1.8%) 1 (0.7%) .307
Intensive care unit stay (h) 21 (11-389) 39 (12-480) .047
Hospital stay (d) 6 (2-33) 6 (2-27) .846
Hospital mortality 1 (0.3%) 3 (2.0%) .091
Observed/expected
mortality ratio
EuroSCORE 0.15 1.00
STS risk score 0.51 3.51
Interval to activities (d)
Walking outside 7 (3-180) 7 (3-90) .556
Household work 17 (4-360) 17 (7-120) .205
Driving 21 (5-90) 21 (5-60) .372
Full activity, including sports 50 (10-365) 44 (7-720) .954
Data presented as n (%) or median (range). TECAB, Total endoscopic coronary artery
bypass grafting; ECMO, extracorporeal membrane oxygenation; CVVH, continuous
venovenous hemofiltration; EuroSCORE, European System for Cardiac Operative
Risk Evaluation; STS, Society of Thoracic Surgeons.
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Dendoscopically (Table 3). The operative times are also listed
in Table 3. The operative times were consistently longer
for the completely endoscopic double-vessel TECAB
procedures.
The postoperative results are listed in Table 4. In-hospital
mortality was 0.3% (1/334) for single-vessel TECAB and
2.0% (3/150) for double-vessel TECAB (P ¼ .090).
When the single-surgeon learning curve cases were ex-
cluded from the analysis, the hospital mortality was 0.5%
(1/221) for single-vessel TECAB and 0.0% (0/45) for
double-vessel TECAB (P ¼ .831) and the mortality was
less than predicted using both the Society of Thoracic Sur-
geons risk score and the European System for Cardiac Op-
erative Risk Evaluation.
The ventilation timewas 2 hours longer for double-vessel
TECAB, and a trend toward an increased rate of postoper-
ative pulmonary infections was noted in patients undergo-
ing double-vessel TECAB. With double-vessel TECAB,
patients required, on average, 2 U of blood compared
with the 1 U needed perioperatively with single-vessel
TECAB. No significant difference was seen in the hospital
length of stay. Patients in both groups had a quick return to
normal activities, and no differences were seen between pa-
tients after single- and double-vessel TECAB with respect
to this endpoint.
The5-year survivalwas93.9% after single-vesselTECAB
and 95.8% after double-vessel TECAB (P¼ .708; Figure 1).
Freedomfromangina showeda trend in favor of single-vessel
TECAB, but the difference was not statistically significant
(Figure 2). The freedom from major adverse cardiac and ce-
rebral events at 5 years was approximately 10% lower after
double-vessel TECAB (Figure 3). However, this difference
also did not reach statistical significance.DISCUSSION
Our series of 150 double-vessel TECAB operations has
demonstrated that increasingly complex endoscopicTABLE 3. Intraoperative results
Variable
Single-vessel
TECAB
Double-vessel
TECAB
P
value
Patients (n) 334 150
Conversion to larger
thoracic incision
31 (9.3%) 31 (20.7%) .001
Any intraoperative
technical problem
110 (32.9%) 66 (44.0%) .019
Operative time (min)
Including angiography 285 (112-690) 402 (183-1050) <.001
Surgery 240 (112-650) 375 (168-795) <.001
Aortic dissection 3 (0.9%) 1 (0.7%) .634
Upper/lower extremity ischemia 2 (0.6%) 1 (0.7%) .602
Data presented as n (%) or median (range). TECAB, Total endoscopic coronary artery
bypass grafting.
The Journal of Thoracic and Carcoronary artery bypass surgery is feasible and reproducible.
Compared with single-vessel TECAB, the procedure
appears technically more demanding, as reflected by the
longer operative times and greater conversion rate. Addi-
tionally, this complexity results in postoperative morbidity,
such as increased blood transfusion requirements and
greater ventilation times. However, the hospital stay was
similar and patients recovered equally quickly after single-
and double-vessel TECAB. No difference was seen in long-
term outcomes, and we found only a slight trend favoring
single-vessel TECAB with respect to freedom from symp-
toms and major adverse cardiac and cerebral events.
Patient Selection
We chose a relatively low-risk cohort with a predicted
mortality of 2% according to the European System for
Cardiac Operative Risk Evaluation and a predicted mortality
of 0.5% according to Society of Thoracic Surgeons risk
score. Patients undergoing double-vessel TECAB had had
previous myocardial infarcts more frequently and had
a greater incidence of cerebrovascular disease than did
patients undergoing single-vessel TECAB.Patients requiring
dialysis underwent only single-vessel TECAB to avoid long,
complex procedures in this specific risk group. Also, only 1diovascular Surgery c Volume 144, Number 5 1063
FIGURE 1. Cumulative survival in patients after single- and double-
vessel total endoscopic coronary artery bypass grafting (TECAB).
FIGURE 3. Cumulative freedom frommajor adverse cardiac and cerebral
events (MACCE) in patients after single- and double-vessel total endo-
scopic coronary artery bypass grafting (TECAB).
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Dof 3 operations in the single-vessel group was a learning
curve case, but 70% of the double-vessel cases were within
a single surgeon’s learning curve. The perioperative mortal-
ity was 0% and 0.5% for single- and double-vessel TECAB,
respectively, after these learning curves were overcome.FIGURE 2. Cumulative freedom from angina in patients after single- and
double-vessel total endoscopic coronary artery bypass grafting (TECAB).
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The present series has demonstrated that a variety of
total endoscopic coronary artery bypass grafting (CABG)
procedures can be performed. Both arterial and venous
grafts can be used, and beating heart and arrested heart ap-
proaches are feasible. The first double-vessel TECAB was
reported by Kappert and colleagues1 in 2000, in which
a right ITA to the left anterior descending artery and left
ITA to the obtuse marginal branch were placed using an ar-
rested heart technique. The beating heart version of this pro-
cedure was first described in 2004.2
We performed our initial double-vessel TECABs using
the arrested heart technique, because we believed a com-
pletely unloaded and flaccid heart would better facilitate ro-
tation and access to the side and back walls of the heart. We
described a specific exposure technique for accessing the
circumflex coronary artery system in 2006.7 In select beat-
ing heart cases, exposure of the side and back walls of the
heart was enhanced by unloading the left ventricle ‘‘on
pump.’’6,8
Our study has also demonstrated that sequential or so-
called jump grafts can be performed reproducibly in the
closed chest. The group from Frankfurt, Germany intro-
duced this sequential endoscopic bypass grafting technique
in 2002 and published a preliminary series.9 We also
showed that Y-grafts have become a part of the armamentar-
ium of robotic endoscopic coronary surgeons. Balkhy and
colleagues,10 in their recent series of 120 patients undergo-
ing TECAB using automated anastomotic connectors, alsogery c November 2012
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Dperformed sequential grafts and Y-graft constructs. Because
the performance of aortocoronary bypass grafts is difficult
in the completely endoscopic setting, we regard the devel-
opment of sequential and Y-grafts as a major step in proce-
dure development.
Operative Times and Conversion Rates
Our data have revealed that double-vessel TECAB has
significantly increased operative time requirements com-
pared with single-vessel procedures. The double-vessel op-
erative time was about 6 hours; however, ideal cases can be
performed in only 4 hours. Few data are available regarding
the time requirements for double-vessel TECAB performed
by other groups. Dogan and colleagues9 reported an opera-
tive time of 7 hours for sequential left ITA to left anterior
descending artery and diagonal branch bypasses during
a learning curve period. The earliest TECAB reports on
double-ITA grafting reported an operative time of 6 hours
for arrested heart and 5.5 hours for beating heart proce-
dures.1,2 In their 2010 report, Srivastava and colleagues11
reported a time of 5 hours, 20 minutes for double-vessel
beating heart TECAB and approximately 3 hours for
single-vessel procedures.
Because of the complexity of double-vessel TECAB op-
erations, a greater rate of conversion to a larger thoracic in-
cision was expected when we started our program.
Significant conversation rates have been reported in other
intricate robotic procedures, such as Whipple operations
and endoscopic cystectomy for bladder cancer.12,13 Our
conversion rate of 20.7% for double-vessel TECAB was
comparable to the conversion rates described in early
single-vessel TECAB series, which were in the 20%
range.9,14,15 A decrease in the conversion rate to about 5%
has been described for single-vessel TECAB as one prog-
resses beyond the learning curve,6 and we expect to see
this decrease with double-vessel TECAB as well.
Postoperative Course
More postoperative clinical events occurred after double-
vessel TECAB than after single-vessel TECAB. However,
our first 150 double-vessel TECAB cases represented our
early experience and 70% of the cases were within the
learning curve. In contrast, one third of our single-vessel
TECABs were learning curve cases. Dogan and col-
leagues,9 in 2002, also reported longer intensive care unit
and hospital stays for patients undergoing total endoscopic
left anterior descending artery and diagonal branch sequen-
tial grafts. This too, however, was a very early learning
curve experience.
We chose a threshold of 20 cases to define our learning
curve. From our experience, both the time needed to com-
plete a specific procedural task (eg, ITA harvesting, anasto-
motic suturing) and the total operative time began to
improve significantly after the first 20 cases. Nevertheless,The Journal of Thoracic and Cara triple digit number of cases is likely needed to achieve
a steady state in terms of consistent task-specific and total
operative times. Moreover, only with this many cases, can
one attain a high level of comfort.
Morbidity after double-vessel TECAB mainly affected
the respiratory system. Prolonged periods of single-lung
ventilation most likely contributed significantly to this find-
ing. Patients undergoing double-vessel TECAB received,
on average, 2 U of blood perioperatively. We have recently
illustrated that the causes for blood transfusions after ar-
rested heart TECAB are multifactorial.16 It can be antici-
pated that with additional technical improvements, the
blood transfusion requirements in double-vessel TECAB
will likely decrease. An additional contributor to morbidity
with double-vessel TECAB is addressed by our recent find-
ing that a clear correlation exists between the operative
times and conversion to a larger incision.16 Hence, improv-
ing operative times and avoiding the technical problems that
lead to these conversions will be imperative in decreasing
perioperative morbidity as we move forward.
Concerning mortality, our results did seem to meet the
current quality standards, because they were in line with
the mortality rates reported in contemporary studies. For ex-
ample, in their series of 68 double-vessel and 139 single-
vessel TECABs, Srivastava and colleagues11 observed no
mortalities in nonconverted cases. Balkhy and colleagues,10
in a mixed series of single- and double-vessel TECABs, re-
ported an overall 30-day mortality of 0.8%. Risk scores
were unavailable from either study, however, and in the lat-
ter study, 10 very early learning curve cases were excluded.
A significant decrease inmortality was observed in our pres-
ent series after the initial learning curve had been overcome.
Early Rehabilitation Phase
Our data have shown that after both single- and double-
vessel TECAB, patients are able to return to their normal
activities more quickly than those undergoing traditional
coronary bypass surgery through sternotomy. Patients
returned to full activity levels—including sports—within
6 to 7 weeks, far shorter than the 10-week period of sternal
precautions usually recommended after standard CABG.
Kon and colleagues17 previously demonstrated similar find-
ings after robotically assisted coronary bypass surgery
through minithoracotomy. Our Innsbruck team has also
shown that after TECAB, patients have advantages with re-
spect to postoperative rehabilitation compared with those
who underwent sternotomy and those converted to sternot-
omy.18 We believe these quality of life data justify the in-
vestment of longer operative times and the technical
challenges of robotic surgery.
Intermediate-Term Results
Currently, no published data are available on the interme-
diate- or long-term results after multivessel TECAB. Ourdiovascular Surgery c Volume 144, Number 5 1065
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as was observed for our single-vessel procedures. More-
over, our intermediate-term results have demonstrated that
our freedom from angina and freedom from major adverse
cardiac and cerebral events were comparable to the results
seen after open CABG reported in classic comparative trials
such as the Arterial Revascularization Therapies Study,
thereby further demonstrating that multivessel robotic inter-
ventions are safe in the intermediate term.19CONCLUSIONS
Having performed 150 double-vessel TECAB proce-
dures, this operation appears to be reproducible and safe.
The technical performance and perioperative results, at
present, are slightly inferior to the postlearning curve results
for single-vessel TECAB. However, the intermediate-term
freedom from symptoms and freedom from adverse events
seem to be comparable to the results seen for single-vessel
TECAB and meet the standards of open CABG using the
traditional sternotomy approach. The learning curve effects
are visible.References
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